Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelination

SJ. McKie, AS. Nicholson, E. Smith, S. Fawke, ER. Caroe, JC. Williamson, BG. Butt, D. Kolářová, O. Peterka, M. Holčapek, PJ. Lehner, SC. Graham, JE. Deane

. 2023 ; 120 (14) : e2218823120. [pub] 20230330

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
219447/Z/19/Z Wellcome Trust (WT)
MR/N020626/1 UKRI | Medical Research Council (MRC)
210688/Z/18/Z Wellcome Trust (WT)

E-resources Online Full text

NLK Free Medical Journals from 1915 to 6 months ago
Freely Accessible Science Journals from 1915 to 6 months ago
PubMed Central from 1915 to 6 months ago
Europe PubMed Central from 1915 to 6 months ago
Open Access Digital Library from 1915-01-15
Open Access Digital Library from 1915-01-01

Myelin is a multilayered membrane that tightly wraps neuronal axons, enabling efficient, high-speed signal propagation. The axon and myelin sheath form tight contacts, mediated by specific plasma membrane proteins and lipids, and disruption of these contacts causes devastating demyelinating diseases. Using two cell-based models of demyelinating sphingolipidoses, we demonstrate that altered lipid metabolism changes the abundance of specific plasma membrane proteins. These altered membrane proteins have known roles in cell adhesion and signaling, with several implicated in neurological diseases. The cell surface abundance of the adhesion molecule neurofascin (NFASC), a protein critical for the maintenance of myelin-axon contacts, changes following disruption to sphingolipid metabolism. This provides a direct molecular link between altered lipid abundance and myelin stability. We show that the NFASC isoform NF155, but not NF186, interacts directly and specifically with the sphingolipid sulfatide via multiple binding sites and that this interaction requires the full-length extracellular domain of NF155. We demonstrate that NF155 adopts an S-shaped conformation and preferentially binds sulfatide-containing membranes in cis, with important implications for protein arrangement in the tight axon-myelin space. Our work links glycosphingolipid imbalances to disturbance of membrane protein abundance and demonstrates how this may be driven by direct protein-lipid interactions, providing a mechanistic framework to understand the pathogenesis of galactosphingolipidoses.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010498
003      
CZ-PrNML
005      
20230801132448.0
007      
ta
008      
230718s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1073/pnas.2218823120 $2 doi
035    __
$a (PubMed)36996106
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a McKie, Shannon J $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
245    10
$a Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelination / $c SJ. McKie, AS. Nicholson, E. Smith, S. Fawke, ER. Caroe, JC. Williamson, BG. Butt, D. Kolářová, O. Peterka, M. Holčapek, PJ. Lehner, SC. Graham, JE. Deane
520    9_
$a Myelin is a multilayered membrane that tightly wraps neuronal axons, enabling efficient, high-speed signal propagation. The axon and myelin sheath form tight contacts, mediated by specific plasma membrane proteins and lipids, and disruption of these contacts causes devastating demyelinating diseases. Using two cell-based models of demyelinating sphingolipidoses, we demonstrate that altered lipid metabolism changes the abundance of specific plasma membrane proteins. These altered membrane proteins have known roles in cell adhesion and signaling, with several implicated in neurological diseases. The cell surface abundance of the adhesion molecule neurofascin (NFASC), a protein critical for the maintenance of myelin-axon contacts, changes following disruption to sphingolipid metabolism. This provides a direct molecular link between altered lipid abundance and myelin stability. We show that the NFASC isoform NF155, but not NF186, interacts directly and specifically with the sphingolipid sulfatide via multiple binding sites and that this interaction requires the full-length extracellular domain of NF155. We demonstrate that NF155 adopts an S-shaped conformation and preferentially binds sulfatide-containing membranes in cis, with important implications for protein arrangement in the tight axon-myelin space. Our work links glycosphingolipid imbalances to disturbance of membrane protein abundance and demonstrates how this may be driven by direct protein-lipid interactions, providing a mechanistic framework to understand the pathogenesis of galactosphingolipidoses.
650    _2
$a lidé $7 D006801
650    12
$a sulfoglykosfingolipidy $7 D013433
650    _2
$a glykosfingolipidy $x metabolismus $7 D006028
650    _2
$a transportní proteiny $x metabolismus $7 D002352
650    _2
$a neurotrofní faktory $x metabolismus $7 D009414
650    _2
$a myelinová pochva $x metabolismus $7 D009186
650    _2
$a molekuly buněčné adheze $x metabolismus $7 D015815
650    12
$a demyelinizační nemoci $x patologie $7 D003711
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nicholson, Alex S $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
700    1_
$a Smith, Emily $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK $1 https://orcid.org/0000000224196146
700    1_
$a Fawke, Stuart $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
700    1_
$a Caroe, Eve R $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK $1 https://orcid.org/000000033529024X
700    1_
$a Williamson, James C $u Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0AW, UK
700    1_
$a Butt, Benjamin G $u Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK
700    1_
$a Kolářová, Denisa $u Department of Analytical Chemistry, University of Pardubice, Pardubice 53210, Czech Republic $1 https://orcid.org/000000033749625X
700    1_
$a Peterka, Ondřej $u Department of Analytical Chemistry, University of Pardubice, Pardubice 53210, Czech Republic
700    1_
$a Holčapek, Michal $u Department of Analytical Chemistry, University of Pardubice, Pardubice 53210, Czech Republic $1 https://orcid.org/0000000339781249 $7 ola2002159192
700    1_
$a Lehner, Paul J $u Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0AW, UK $1 https://orcid.org/0000000193831054
700    1_
$a Graham, Stephen C $u Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK $1 https://orcid.org/0000000345474034
700    1_
$a Deane, Janet E $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK $1 https://orcid.org/0000000248630330
773    0_
$w MED00010472 $t Proceedings of the National Academy of Sciences of the United States of America $x 1091-6490 $g Roč. 120, č. 14 (2023), s. e2218823120
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36996106 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132445 $b ABA008
999    __
$a ok $b bmc $g 1963114 $s 1196763
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 120 $c 14 $d e2218823120 $e 20230330 $i 1091-6490 $m Proceedings of the National Academy of Sciences of the United States of America $n Proc Natl Acad Sci U S A $x MED00010472
GRA    __
$a 219447/Z/19/Z $p Wellcome Trust (WT)
GRA    __
$a MR/N020626/1 $p UKRI | Medical Research Council (MRC)
GRA    __
$a 210688/Z/18/Z $p Wellcome Trust (WT)
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...